Cover Image

Ustekinumab for acute steroid-refractory gut GVHD: A novel agent

Saved in:

Bibliographic Details
Main Authors:	Nirali Sanghvi (Author), Manam Mehra (Author), Santanu Sen (Author)
Format:	Book
Published:	Elsevier, 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Deferasirox-induced acute liver failure
by: Nirali Sanghvi, et al.
Published: (2024)

Novel and Promising Strategies for Therapy of Post-Transplant Chronic GVHD
by: Irina Kostareva, et al.
Published: (2022)

Pityriasis Rubra Pilaris refractory to ustekinumab successfully treated with guselkumab
by: João Teixeira, et al.
Published: (2024)

Refractory metastatic Crohn's disease responsive to ustekinumab dose intensification
by: Teresa L. Xiao, BA, et al.
Published: (2023)

The significance of M1‐polarized CD163+ macrophages in acute graft‐versus‐host disease (GVHD): Possible mechanisms of GVHD in the development of skin lesions
by: Yusuke Muto, et al.
Published: (2023)

High Diversity but Monodominance of Multidrug-Resistant Bacteria in Immunocompromised Pediatric Patients with Acute Lymphoblastic Leukemia Developing GVHD Are Not Associated with Changes in Gut Mycobiome
by: Sara Sardzikova, et al.
Published: (2023)

The role of chemokines in mediating graft versus host disease (GVHD): opportunities for novel therapeutics
by: Marina Gomes Miranda Castor, et al.
Published: (2012)

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
by: Abedin S, et al.
Published: (2020)

Ustekinumab trough levels in children with Crohn's disease refractory to anti-tumor necrosis factor agents: a prospective case series of off-label use
by: Marleen Bouhuys, et al.
Published: (2023)

Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute gut graft-versus-host disease after pediatric allogeneic stem cell transplantation
by: Faizuddin Ansari, et al.
Published: (2017)

The Role of Bacteria and Pattern Recognition Receptors in GvHD
by: E. Holler, et al.
Published: (2010)

Ustekinumab
by: Murat Borlu
Published: (2022)

Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) - Case series
by: Ashley N. Gray, et al.
Published: (2023)

Therapeutic Effects of HLA-G5 Overexpressing hAMSCs on aGVHD After Allo-HSCT: Involving in the Gut Microbiota at the Intestinal Barrier
by: Bu X, et al.
Published: (2023)

Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease
by: Camila Derminio Donadel, et al.
Published: (2023)

Efficacy of combination therapy of steroid and methotrexate for refractory pemphigus
by: Miwa Kanaoka, et al.
Published: (2021)

Dapsone: a steroid-sparing drug for refractory immunoglobulin A vasculitis?
by: Jin-Soon Suh
Published: (2020)

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn's disease
by: Klaudia Miklusiak, et al.
Published: (2023)

Genital GVHD in Female Children and Adolescents: A Systematic Review of Case Reports and Case Series
by: Maria Tsimeki, et al.
Published: (2023)

Paradoxical granulomatous reaction to ustekinumab
by: Chinemelum Obijiofor, et al.
Published: (2024)

Ustekinumab: differential use in psoriasis
by: Uhlenhake EE, et al.
Published: (2011)

Late reaction to ustekinumab infusion
by: Marina Resener Morais, et al.
Published: (2013)

Efficacy and safety of ustekinumab in adolescents
by: Kellen R, et al.
Published: (2016)

Frasier Syndrome: A Rare Cause of Refractory Steroid-Resistant Nephrotic Syndrome
by: Yung-Chieh Huang, et al.
Published: (2021)

Modulation of Immunoregulatory Properties of Mesenchymal Stromal Cells by Toll-Like Receptors: Potential Applications on GVHD
by: Bruno Sangiorgi, et al.
Published: (2016)

Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases
by: Irina Zaidman, et al.
Published: (2023)

Human Amniotic Mesenchymal Stem Cells Inhibit aGVHD by Regulating Balance of Treg and T Effector Cells
by: Gao Y, et al.
Published: (2021)

Steroid Refractory Figurate Eruption with Eosinophilia in a Young Adult Man: A Quiz
by: Gabriela Żuk, et al.
Published: (2021)

Paediatric pyoderma gangrenosum treated with ustekinumab
by: Emanuele Savasta, et al.
Published: (2024)

Ustekinumab for the treatment of psoriatic arthritis: an update
by: Davari P, et al.
Published: (2014)

Interstitial Granulomatous Drug Reaction to Ustekinumab
by: A. Walker, et al.
Published: (2022)

Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis
by: Bayanne Olabi, et al.
Published: (2020)

Ustekinumab-induced fixed drug eruption
by: Dhafer M. Hafez, MD, et al.
Published: (2020)

Topical Tacrolimus and Periodontal Therapy in the Management of a Case of Oral Chronic GVHD Characterized by Specific Gingival Localization
by: Davide Conrotto, et al.
Published: (2014)

Quality of life of patients with graft-versus-host disease (GvHD) post-hematopoietic stem cell transplantation
by: Sibéli de Fátima Ferraz Simão Proença, et al.

Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis
by: Maeve Lynch, MD, MBBChBAO, et al.
Published: (2017)

Plurifocal cutaneous leishmaniasis during treatment with ustekinumab
by: Louva Rakotonarivo, MD, et al.
Published: (2018)

Clinical utility of ustekinumab in Crohn’s disease
by: Kotze PG, et al.
Published: (2018)

Refractory seizures with encephalopathy may be due to Hashimoto encephalopathy
by: Atraya Samanta, et al.
Published: (2023)

Exploring the gut microbiota's crucial role in acute pancreatitis and the novel therapeutic potential of derived extracellular vesicles
by: Yijie Li, et al.
Published: (2024)